CytoMed Therapeutics Ltd
CytoMed Therapeutics Ltd (GDTC): ~2 mo cash runway. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
2.1 months
D/E 0.17 · 0% dilution
N/A
N/A
N/A
N/A
A transparent, data-derived signal for CytoMed Therapeutics Ltdacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$13.6M
Cash
$1.6M
Quarterly Burn
$2.9M
Runway
2.1 mo
Revenue
$252K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
2
Total value held
$10K
| Holder | Shares | Value |
|---|---|---|
| xtx topco ltd | 10,136 | $10K |
| osaic holdings, inc. | 21 | $21 |
Frequently asked questions
What is CytoMed Therapeutics Ltd's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CytoMed Therapeutics Ltd has approximately 2.1 months of cash runway.
What is CytoMed Therapeutics Ltd's market capitalization?
CytoMed Therapeutics Ltd's market capitalization is approximately $13.6M.
Get the full picture on CytoMed Therapeutics Ltd
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.